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SUMMARY KEYWORDS
We analyzed the molecular mechanisms
involved in the acquisition and maturation of
dopaminergic (DA) neurons generated in vitro
from rat ventral mesencephalon (MES) cells in the
presence of mitogens or specific signaling
molecules. The addition of basic fibroblast growth
factor (bFGF) to MES cells in serum-free medium
stimulates the proliferation of neuroblasts but
delays DA differentiation. Recombinant Sonic
hedgehog (SHH) protein increases up to three fold
the number of tyrosine hydroxylase (TH)-positive
cells and their differentiation, an effect abolished
by anti-SHH antibodies. The expanded cultures
are rich in nestin-positive neurons, glial cells are
rare, all TH
+ neurons are DA, and all DA and
GABAergic markers analyzed are expressed.
Adding ascorbic acid to bFGF/SHH-treated
cultures resulted in a further five- to seven-fold
enhancement of viable DA neurons. This
experimental system also provides a powerful tool
to generate DA neurons from single embryos. Our
strategy provides an enriched source ofMES DA
neurons that are useful for analyzing molecular
mechanisms controlling their function and for
experimental regenerative approaches in DA
dysfunction.
Reprint requests to: Dr. Floriana Volpicelli, IGB, CNR, Via P.
Castellino 111, 80135 Naples, Italy; e-mail: volpicel@igb.cnr.it
Nurrl, tyrosine hydroxylase, primary cultures, bFGF,
SHH.
INTRODUCTION
In mammals, three important contingents of
dopaminergic (DA) neurons, consisting of the
retrorubral nucleus, the substantia nigra, and the
ventral tegmental area, are located in the ventral
midbrain and form the nigrostriatal and the meso-
cortico-limbic DA pathways. These circuits
regulate movement control, reward, and emotional
behavior, as well as motivation. Degeneration of
the ascending nigro-striatal pathway is associated
with Parkinson’s disease. Disturbance in the meso-
cortico-limbic system has been associated with
schizophrenia, addictive behavioral disorders and
attention-deficit hyperactivity disorder (ADHD)
(Swanson, 1998; Hale, 2000). Considerable
information has accumulated on the complex
cellular and molecular mechanisms of midbrain
patterning and DA phenotypic induction, develop-
ment and maturation (di Porzio, 1999). In the
midbrain, DA phenotype is determined by the
action of two extracellular inducers" Sonic
hedgehog (SHH) protein, a widespread morphogen
produced by the floor plate and notochord, and
fibroblast growth factor 8 (FGF8), produced by the
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isthmus (Hynes, 1995; Hynes, 1999; Wang, 1995).
These factors activate cascades of other signaling
molecules and transcription factors among which,
Nurrl and Ptx3. The former is essential for the
differentiation of DA neurons in both the ventral
tegmental area and substantia nigra (Zetterstrom,
1997), whereas the latter is required for the
development of SN but not ventral tegmental area
DA neurons (Nunes, 2003; Smidt, 2004).
Committed and determined DA neurons express
the key genes necessary forDA neurotransmission,
such as the TH, vesicular monoamine transporter
(VMAT2), and DA transporter (DAT) genes, at
different times during development. Tyrosine
hydroxylase, the rate-limiting enzyme in
catecholamine biosynthesis, is expressed early
during embryogenesis (E9) (di Porzio, 1990). The
VMAT2, which concentrates biogenic amines in
the dense core vesicles, is also expressed early in
mesencephalic (MES) development. The DAT, a
specific marker of DA neurons, is responsible for
the high affinity uptake of DA, a function that
appears at later stages of DA development when
compared with otherDA markers, both in vivo and
in vitro (di Porzio, 1980; Perrone-Capano, 2000).
The formation of midbrain DA circuits requires a
proper matching between targets and presynaptic
elements (Perrone-Capano, 2000; Zuddas, 1991).
Striatal target neurons exert a beneficial and
necessary effect on the maturation and function of
presynaptic DA neurons, thereby modulating DAT
and its function (di Porzio, 1980; Fiszman, 1991;
Prochiantz, 1979; Perrone-Capano, 1996).
The DA neuronal culture technique is a useful
tool to study molecular mechanisms involved in
the development and maintenance of these
neurons. Due to the fundamental role played by
midbrain DA neurons in mammalian physiology
and in human pathology, the generation of a large
number of DA neurons has been explored by
different approaches: expansion of committed DA
neuron precursors (Studer, 1998; Ling, 1998;
Potter, 1999), induction of immortalized neural
cells to adopt a DA fate by gene transfection
(Wagner, 1999), expansion and differentiation of
embryonic and neural stem cells (Lee, 2000;
Chung, 2002), transgenic approaches (Brodsky,
2003; Puelles, 2003).
Indeed, the question of whether DA neurons
can interact with their proper target and form
functional DA circuits, independently from their
anatomical and functional origin, is still open
because the interaction between embryonic and
adult neurons in the nigrostriatal pathway is highly
selective. For instance, only DA neurons obtained
from MES, but not from other CNS regions, are
able to restore function when gratted into mouse
hosts with lesioned nigrostriatal system (Zuddas,
1990). This phenomenon supports the view that
new approaches are needed to generate large
number ofDA neurons ofMES origin.
In this study, we present a method to obtain DA
neurons in high yield from ventral MES precursors.
We expanded the neuroblasts by the action of the
mitogen basic fibroblast growth factor (bFGF) and
promoted their DA differentiation in the presence of
specific signaling molecules.
EXPERIMENTAL
Animals and dissections
Timed pregnant Sprague-Dawley rats (Charles
River Breeding Laboratories, Milan, Italy) were
sacrificed in accordance with Society for Neuro-
science guidelines and Italian law. The embryonic
age (E) was determined by considering the day of
insemination (as confirmed by vaginal plug) as day
E0. Embryos from day 12 (El2) of gestation were
quickly removed and placed in phosphate buffered
saline (PBS), without calcium and magnesium, and
supplemented with 33 mM glucose. The ventral
MES was carefully dissected under a stereoscope in
sterile conditions and processed for cell cultures.
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dissociation. A similar approach was applied to
mouse embryos, with all conditions being the same
except that the gestation stage was E11. In many
cases cultures were also generated from single
embryos.
Cell cultures
Cells were dissociated from embryonic rat
ventral MES and cultured as previously described
(di Porzio, 1980). Briefly, the tissues were
dissected from El2 embryos and dissociated by
mechanical trituration with a fire polished Pasteur
pipette in culture medium (see below) and 0.01%
pancreatic deoxyribonuclease (Sigma, Milan, Italy),
centrifuged for 5 min at 700 rpm, suspended in
plating medium, and counted.
Standard culture conditions: Cells were plated
at a density of 125.000/cm2 (24-multiwell plates,
Costar, Milan, Italy), in dishes coated with 15
micrograms/mL of poly-D-Lysine (Sigma). Cells
were grown in Neurobasal medium (Invitrogen,
Milan, Italy) containing L-glutamine (0.5 mM,
Sigma), 7.5% fetal bovine serum (HyClone
Laboratories Inc., Milan, Italy), 5% horse serum
(Euroclone, Milan, Italy). Cytosine 13-D-
arabinofuranoside, 5 micromolar, (AraC, Sigma)
was added to the cultures after 3 days in vitro
(DIV) to inhibit non-neuronal cell proliferation.
Expanded cultures: cells were dissociated
from El2 MES as described above and plated at a
density of 18.000/cm2 (24-multiwell plates), as
above. Cells were grown as above in the absence
of serum but with the addition of B27 supplement
(Invitrogen), bFGF (20 ng/mL, Sigma) and the N-
terminal fragment of the Sonic hedgehog (SHH)
protein (50 ng/mL), and in some cultures ascorbic
acid (Sigma, 200 micromolar) was added at 6 DIV.
Half the medium was changed every 3 days; bFGF
and SHH were withdrawn at various DIV, as
indicated. AraC was never added.
[3H]-DA uptake
[3H]-DA uptake was performed as previously
described (Prochiantz, 1979). Briefly, cultures
were washed in PBS containing 33 mM glucose,
mM CaC12 and MgCI2 and incubated for 15 min in
the same buffer containing 50 nM [7,8-3H]-DA
(S.A. 40-60 Ci/ mmol, Amersham Biosciences,
Milan, Italy) at 37C or at 0C (to obtain blank
values). After three washes with cold PBS, cells
were dissolved in 0.2 ml of Triton X-100 (0.2%)
and 0.2 N NaOH, then neutralized with equimolar
concentrations of HCI and counted in 5 mL
Biodegradable counting scintillant (Amersham) in
a Beckman liquid scintillation counter. The uptake
was calculated by subtracting blank values from
the amount of radioactivity accumulated at 37C.
Cultures were always grown in at least triplicate
samples for each experimental point and were
processed separately.
RT-PCR analyses
RNA was extracted from single cultures, using
the Tri-Reagent isolation system (Sigma) and
following the manufacturer’s instructions. Cultures
for each experimental point were analyzed and
processed separately. The yield and integrity ofthe
RNA were determined by the spectrophotometric
measurement of A260 and by agarose-gel
electrophoresis, respectively. RT-PCR analyses
were done as previously described (Perrone-
Capano, 1994; Pemas-Alonso 1999). Briefly, total
RNA was treated with a DNA-free kit (Ambion
Inc., Milan, Italy) to prevent false results from
DNA contamination. Two micrograms of RNA
were reverse transcribed using random hexa-
nucleotides as primers (New England Biolabs Inc.,
Milan, Italy, 6 micromolar), 20 U of Rnasin
(Ambion) and 200 U of Moloney-murine leukemia
virus reverse transcriptase (Ambion). One
twentieth of the reverse transcribed eDNA was48 FLORIANA VOLPICELLI ET AL.
amplified in a 25 microliters of reaction mixture
containing AmpliTaq Gold DNA polymerase
buffer (Applied Biosystems, Milan, Italy), 0.2 mM
dNTPs (Finnzymes OY, Espoo, Finland), 0.4
micromolar each primer, U AmpliTaq Gold DNA
polymerase (Applied Biosystems) and microcurie
[32p]dCTP (3000 Ci/mmol, Amersham).
Different sets of primer pairs were used in the
same reaction tube to co-amplify eDNA, together
with primers for the hypoxantine-phosphoribosyl-
transferase (HPRT) gene, which is constantly
expressed during CNS development, used as an
internal standard (Steel, 1993). After a first
denaturing step for 8 min at 95C, PCR
amplification was performed for 27 cycles,
organized as follows: 95 C for 30 see; 56C to
58C for 30 see; 72C for 40 see, followed by a
final extension step (72C for 5 min). The number
of cycles was experimentally chosen to fall into
the exponential phase of the amplification
reaction. The forward and reverse primers (MWG-
Biotech, Ebersberg, Germany) used are listed in
Table 1, together with the length of amplified
fragments. The specificity of PCR primers was
determined by performing BLAST searches
against the databases. Non-reverse-transcribed
RNA templates and mock controls, always run in
the PCR reactions, never produced amplification
products. The identity of each amplified fragment
was confirmed by size (see Table 1) and by
digestion with restriction enzymes or by sequence
analysis.
The [32p]-labeled amplified products were
separated by electrophoresis in 1.5% agarose gel,
dried, and exposed to a Phosphorlmager screen.
Quantization was achieved by integrating the
volume areas of each fragment obtained from
scanning the screens with a Phosphorlmager
apparatus (Molecular Dynamics, Sunnyvale,
California, USA), equipped with ImageQuant
software. The ratio between the yield of each
amplified product and that of co-amplified HPRT
allowed a relative estimate of mRNA levels
(Pemas-Alonso, 1999). Triplicate samples allowed
statistical analysis (see below).
Immunocytochemistry
Tyrosine hydroxylase immunostaining" MES
cell cultures were fixed for 30 min at room
temperature in 4% paraformaldehyde in PBS,
permeabilized for 15 min in PBS containing 0.1%
Triton X-100 (unless indicated otherwise) and
10% normal goat serum, and incubated for 2 h at
24C in PBS containing 10% normal goat serum
and anti-TH antibody (1:200, Chemicon, Milan,
Italy). Mesencephalic cell cultures were stained
according to standard avidin-biotin immunocyto-
chemistry procedures (Vectastain Elite, Vector
Laboratories, Burlingame, California, USA), using
a peroxidase substrate kit (DiAaminoBenzidine).
Control cells were incubated in the same solutions
without primary antibodies and subsequently
processed as above. The TH positive cells were
counted in each well of a Lab-Tek chamber slide
(Nunc, VWR International, Milan), using an
eyepiece grid. Three culture wells were analyzed
in each experiment for each experimental
condition. The length of TH
/ neurites was
analyzed counting randomly 3 points in each well
of a Lab-Tek chamber slide; the number of
neurites for TH
/ neurons was evaluated counting,
always in each well of a Lab-Tek chamber, the
number ofneurites in 20 random neurons.
Sonic hedgehog purification
Escherichia coli strain BL21 was transformed
with a plasmid pGEX-N (girl of P. Beachy), which
expresses the N-terminal fragment of mouse SHH,
and induced with isopropyl-beta-D-thiogalacto-
pyranoside (IPTG). Cells were lysed and cleared
lysates were bound to glutathione-conjugated
Sepharose beads (Pharmacia). The bound fusion
protein was cleaved with a mass of thrombin
(Sigma) equivalent to 1% the mass of fusionENRICHMENT OF MIDBRAIN DOPAMINERGIC NEURONS IN VITRO 49
c-RET
TABLE 1
Primers nucleotide sequence (5’-3’) used for RT-PCR experiments
F. CGCTGCATGAGAATGACTGGA
R. CAAAGCCTCCAGCACATACTTC
F. CGTGCACCAATGTCTTCAGTG
494 bp Nestin
DAT 498 bp NFH
R. ATGGTGAAGGAGGAGAAGAAGT
F. GCTGGAAATGGAAGGTT
EP10 242 bp NFL
R. AGCCCCATCACCGTAGCAAC
F. GCTCTGC_TTTTGGTCCTTC
F. CGCTCAGTGTCGCTTAGA
R. GCCTCCAGCAGAGTCCTGTAT
F. AGCCTGAGGAGAAGCCCAAA
R. CGTAGCGTTCAGCATACATC
F. ACCTCTCCGCCGCTCTCAAG
R. TCTCCTCGACCTCTGTCTGCTCT
F. GAAATGGAAGAAACCCTCACA
273 bp
453 bp
613 bp
GAD65 437 bp NFM 474 bp
R. CCGCCTTGCCTCTGGTTTTGG R. TGCCAATTCCCAATTATACTCTTGA
F. GACCGACTTCTCCAACCTGTT F. CGCGTCGCAGTTGCTTGACAC
GAD67 308 bp Nurrl 449 bp
R. TTGCCTGGAACCTGGAATAGT R. TCCCATCACCATCTTTATTTG
F. GCTGGAGGTGGAGAACA F. TGTCACGTCCCCAAGGTTCAT
GFAP 456 bp TH 276 bp
R. AGGCCGCTCTCTAAGT R. TGCGCGATAGTCGTTAGC
F. CCTGCTGGATTACATTAAAGCACTG F. ATCCAGACCACCAGACCAGAG
HPRT 370 bp VMAT2 616 bp
R. CCCCATCCAAGAGCACCAAGG R.CCTGAAGTACTCATTATAGTCAAGG
The table shows the forward (F.) and reverse (R.) primer sequences with length of amplified fragments (bp) used in RT-
PCR for the following genes: tyrosine kinase receptor Ret (c-Ret), dopamine transporter (DAT), glutamate acid
decarboxylase 65 (GAD65) and 67 (GAD67), the embryonic truncated form of GAD67 (EPI 0), glial fibrillary acidic
protein (GFAP), hypoxantine-phosphoribosyl-transferase (HPRT), Nestin, high neurofilament (NFH), light
neurofilament (NFL), medium neurofilament (NFM), Nurrl, tyrosine hydroxylase (TH), vesicular monoamine
transporter (VMAT2).
protein in 10 mM Tris-HCl (pH 7.5), 150 mM
NaCI, 2.5 mM CaCI2. The protein released from
the beads was batch adsorbed to anti-thrombin-
agarose (Sigma). The SHH protein was purified
from this supernatant by adsorption to heparin-
agarose (Pharmacia) in PBS containing mM
DTT (Sigma) followed by elution in PBS
containing 550 mM NaCI, mM DTT, 10%
glycerin (Sigma). The concentration of SHH was
determined by Bradford assay (Bio-Rad). The
SHH product was detected as a single band of 22
kDa on SDS-PAGE stained with Coomassie blue,
indicating a purity greater than 95%. The purified
protein was aliquot and stored at-80C until use.
Statistical analysis
At least triplicate samples were used in all the
experiments, thus allowing statistical analysis.
Analysis of variance was carried out, followed by
post hoc comparison (ANOVA, Scheff6 F-test).
Data were expressed as mean + SEM.50 FLORIANA VOLPICELLI ET AL.
RESULTS
Expanded MES DA cultures
Establishment of cultures. We used ventral
MES dissected from El2 rat, a time when a large
number of DA precursors are present (di Porzio,
1990) and still proliferating, to study the mitogenic
effect of bFGF on dissociated MES cells in
cultures. Alternatively, mouse E11 embryos were
used. Embryonic ventral MES from various litters
were pooled before dissociation or used to
generate cultures from single embryos. Dissociated
cells were plated at low density (18000 cells/era2),
to avoid differentiating effects caused by cell-cell
interactions, in serum-free medium to prevent glial
cell proliferation. We observed that adding bFGF
(20 ng/mL) at the beginning of the culture was
mandatory to ensure the proliferation ofEl2 MES
cells (Fig. 1). During the first day in vitro, the cells
adopted a spherical morphology and atter 3 days
formed small clusters, which already extended
some neurites as previously described by Bouvier
and Mytilineou (1995). In our conditions, a few
neurons present in these clusters showed
differentiated features of the DA phenotype, as
monitored by anti-TH immunocytochemistry (Fig.
2B). When bFGF was withdrawn, however, we
observed a clear neuronal differentiation of most
cells and obtained an increase in the number of
TH
+ cells. The cultures were treated with the
amino-terminal recombinant fragment of SHH (50
ng/mL) to further enhance DA differentiation.
We tested various combinations of addition/
withdrawal of bFGF and SHH at different DIV.
The cultures, which we called expanded MES DA
cultures, were analyzed 9 to 12 days after plating.
As shown in Fig. 2A, the number of TH
+ cells
stimulated for 9 DIV with bFGF increased,
compared with controls, by 1.5 fold when SHH
was added at 6 DIV, by 2-fold when bFGF was
subtracted after 6 DIV, by 2.5 fold when the cells
were stimulated for 6 DIV with bFGF and
subsequently SHH was added for 3 more DIV. A
greater number of TH
/ cells were obtained when
SHH was added together with bFGF to the
medium at the time of plating and both factors
were withdrawn after 6 DIV. To verify whether
the increased number of TH
+ cells was selectively
due to SHH added to the cultures, neutralizing
antibodies were used to block its activity. On
average, a saturating dose of SHH (50 ng/mL) at
least doubled the number ofTH
+ neurons, whereas
the presence of a five-fold molar excess of anti-
SHH antibodies completely inhibited this response
(Volpicelli, 2004). To verify if the addition of
SHH might have a trophie effect on the expanded
MES cultures, we measured the length, area, and
number of neurites/TH+ cells. No significant
difference was found between bFGF-stimulated
cultures with or without SHH (data not shown).
--
+bF(IF -I- -bFGF
3 6 9 12
DAYS IN VITRO (DIV)
Fig. 1: Expansion ofmesencephalic precursors in vitro.
Comparison of bFGF treated (+bFGF) and
control cultures (-bFGF) at different days in
vitro (DIV). Every value represent the mean +/-
SEM of triplicate samples for each
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Characterization ofexpandedMESDA cultures.
We adopted the condition that induced the
differentiation of a greater number ofTH
+ cells (6
DIV of bFGF and SHH stimulation) to study and
characterize by gene expression analyses and
functional assays, further DA differentiation
occurring in the expanded MES cultures after
withdrawal ofbFGF and SHH (at 9-12 DIV).
The expanded MES DA cultures, analyzed after 12
DIV, contained neural precursors, as shown by the
expression of the nestin gene, and developing or
mature neurons, which expressed light and
medium (NFL, NFM) but not high (NFH)
neurofilament subunits. In different culture
conditions (+/-bFGF; +/-SHH), the expression of
NFL and NFM genes was not significantly
different (Fig. 3). In the cultures treated for 6 days
with bFGF .or with bFGF and SHH, NFL gene
expression was increased about two-fold when
compared with cells plated at high density in the
presence of serum (see Experimental section),
whereas NFM gene expression did not vary in the
two conditions.
To evaluate the presence and the proliferation
of glial cells in MES expanded cultures, we
analyzed the gene expression of glial fibrillary
350
300
250
200
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100
50-
A
> >_>
+ + + + -i- +
Fig. 2: Characterization of expanded MES DA cultures. (A): Number of TH cells in 9 DIV cultures treated with
bFGF (20 ng/ml) for 9 DIV (+bFGF x 9 DIV), with bFGF for 9 DIV and addition ofSHH (50 ng/ml) at 6 DIV
(+bFGF x 9 DIV, +SHH at 6 DIV), with bFGF for 6 DIV (+bFGF x 6 DIV), with bFGF for 6 DIV and
subsequent addition of SHH at 6 DIV (+bFGF x 6 DIV, + SHH at 6 DIV) or plated in the presence of both
bFGF and SHH which are subtracted at 6 DIV (+bFGF x 6 DIV, +SHH x 6 DIV). The bars represent the mean
+/- SEM of triplicate samples for each experimental point. Asterisks represent p<0.01 when compared to
cultures treated with bFGF for 9 DIV (ANOVA, Scheff6 F-test). (B): TH-immunoreactive neurons at 9 DIV,
after stimulation with bFGF and SHH for 6 DIV.52 FLORIANA VOLPICELLI ET AL.
acidic protein (GFAP), the intermediate filament
of astrocytes. The GFAP gene was expressed at
very low levels at any time in expanded cultures,
unless serum was added after 6 days of bFGF
stimulation. In this condition, GFAP gene
expression was greater than that observed in
standard conditions in serum-supplemented growth
medium because in the latter, Ara C was added 3
days after plating to avoid the overgrowth of glial
cells (Fig. 3).
+ ++
NFt/HPRT
NFM/HPRT
GFAP/HPRT
Gene expression in expanded and standard
mesencephalic cultures. The diagrams show the
relative quantization (mean +/- SEM) of the
intermediate filaments light neurofilament
(NFL), medium neurofilament (NFM) and glial
fibrillary acidic protein (GFAP) amplified
product compared to that of the hypoxanthine
phosphoribosyl transferase (HPRT, internal
standard), assessed by RT-PCR. Data are
expressed as ratio NFL/HPRT, NFM/HPRT,
GFAP/HPRT. Expanded MES cultures were
analyzed at 12 DIV after the treatment with
either bFGF for 6 DIV, or bFGF and SHH for
the first 6 DIV, or bFGF for the first 6 DIV and
consequently addition of fetal bovine serum
(FBS) and horse serum (HS), or plated in
standard conditions (see Experimental section).
As GABAergic neurons constitute an important
contingent of ventral MES neurons, we analyzed
the expression of key genes involved in GABA
biosynthesis to evaluate whether the GABAergic
phenotype could also be influenced by treatment
with bFGF and SHH. As expected, the expression
of glutamate acid decarboxylase GAD65, GAD67,
and EP10 genes (the embryonic truncated form of
GAD67) was detectable but was not significantly
different in the different culture conditions tested
(+bFGF; + SHH; data not shown).
In addition, expanded MES DA cultures
expressed all the DA genes analyzed, such as TH,
DAT, Nurrl, VMAT2 (Volpicelli, 2004), and the
tyrosine kinase receptor Ret (c-Ret, Volpicelli,
2004). Different culture conditions (+/-bFGF;
+/-SHH) did not influence the mRNA profiles of
these genes (Fig. 4A).
Recent findings have demonstrated that
ascorbic acid (AA) increases the survival of TH
/
MES precursors (Yan, 2001; Lee, 2003). Thus, we
tested the possibility of enriching TH
/ cells in our
expanded MES cultures using a similar treatment.
The addition ofAA (200 tM) for three days after
six DIV of stimulation with bFGF and SHH led to
a further four-to seven-fold increase in the number
of TH
/ cells, when compared with cultures treated
for 6 DIV with bFGF/SHH alone (Fig. 5A, 5B).
This increase was paralleled by a seven-fold or
greater increase in TH mRNA and a two-fold
increase in DAT mRNA (Fig. 4B). The effect on
the TH mRNA increase was evident only when
AA was added following bFGF and SHH
withdrawal.
To characterize the neuronal maturation of
expanded MES cultures, we tested the ability of
these cells to incorporate [3H]-DA by high affinity
uptake, a function expressed only in differentiated
embryonic DA neurons.
As shown in Fig. 6A, at 12 DIV the [3H]-DA
uptake significantly increased aider bFGF was
withdrawn from the medium after 6 DIV, when
compared with cultures grown for 9 DIV inENRICHMENT OF MIDBRAIN DOPAMINERGIC NEURONS IN VITRO 53
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1,5
0,5
A
Nurrl/HPRT
DAT/HPRT
[] TH/HPRT
11 DAT 496 bp
1 ..Nurr1449bPTH 276 bp i1 HPRT 370 bp
+ bFGF x 6 DIV + bFGF x 6 DIV
+ SHH x 6 DIV + SHH x 6 DIV
+ AA at 6DIV
Fig. 4" Dopaminergic gene expression in expanded and standard mesencephalic cultures. The diagrams show the
relative quantization (mean +/- SEM) ofNurrl, dopamine transporter (DAT) and tyrosine hydroxylase (TH)
amplified product, assessed by RT-PCR, compared to that ofthe hypoxanthine phosphoribosyl transferase
(HPRT, internal standard). Data are expressed as ratio Nurrl/HPRT, DAT/HPRT, TH/HPRT. (A): Expanded
MES cultures were analyzed at 12 DIV after the treatment with bFGF for 6 DIV, or bFGF and SHH for the first
6 DIV, or bFGF for the first 6 DIV and consequently addition of fetal bovine serum (FBS) and horse serum
(HS), or plated in standard conditions (see Experimental section). (B): Expanded MES cultures were analyzed
at 9 DIV after treatment with bFGF and SHH for the first 6 DIV and subsequent administration of ascorbic acid
(AA) for three more days. The gel in the inset shows triplicate samples for each experimental condition of the
co-amplified DAT, Nurrl, HPRT, and TH fragments. The size ofthe amplified products is shown on the right
in base pairs (bp). Asterisks represent p<0.01 when compared to cultures without AA (ANOVA, Scheff6 F-
test).
the presence of bFGF. Interestingly, [3H]-DA
uptake was not influenced by the presence of
SHH. The addition of AA induced a modest
further increase in DA uptake (Fig. 6B).
The reversal of total [3H]-DA uptake by a
selective uptake inhibitor ofDAT (Volpicelli, 2004)
indicates that virtually all TH
+ cells detected in the
expanded MES cultures were DA neurons.
DISCUSSION
Because of the high impact of neurological
diseases, the development of in vitro systems for
generating embryonic neurons has been an
important goal of many laboratories in recent
years. Such approaches are aimed at studying the
molecular and cellular events involved in wide54 FLORIANA VOLPICELLI ET AL.
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+ AA at 6DIV
Fig. 5: The role ofascorbic acid. (A): Cells treated with 200 tM ascorbic acid (AA) at 6 DIV after the stimulation with
bFGF and SHH for to 6 DIV. The bars represent the mean +/- SEM of triplicate samples for each
experimental point. Asterisks represent p<0.01 when compared to cultures withoutAA (ANOVA, Schefti
test). (B): TH-immunoreactive neurons at 9 DIV, after stimulation with bFGF and SHH for 6 DIV and
subsequent addition ofAA for 3 DIV.
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Fig. 6: [3H]-dopamine uptake in expanded MES cultures. (A): [3H]-dopamine uptake at 12 DIV in expanded MES
culture treated with bFGF for the first 6 DIV, or bFGF and SHH for the first 6 DIV, or bFGF for 9 DIV, or
bFGF for 9 DIV and addition ofSHH at 9 DIV. The bars represent the mean +/- SEM of triplicate samples for
each experimental point. Asterisks represent p<0.01 when compared to cultures in presence ofbFGF for 9 DIV
(ANOVA, Scheff F-test). (B): [3H]-dopamine uptake at 9 DIV in expanded MES cultures treated with bFGF
and SHH for the first 6 DIV and subsequent administration ofAA for 3 DIV.ENRICHMENT OF MIDBRAIN DOPAMINERGIC NEURONS IN VITRO 55
spread CNS pathologies involving specific
neuronal populations and at replacing the
degenerated endogenous neurons. Identifying the
conditions required for the induction of neural
cells and the activation of DA-specific
developmental patterns and phenotypes can be
particularly useful for treating the progressive
neurodegenerative disorder Parkinson’s disease
and for studying alterations that. can shed light in
developmental disorders like ADHD.
Here we report a new method to enhance
midbrain DA differentiation and to increase the
number ofMES DA neurons in primary cultures by
exploiting the mitogenic effect of bFGF and the
inductive action ofSHH protein. Administering AA
further enhances the number ofDA neurons. Thus,
our conditions enable an increase of DA neurons.
Interestingly, the DA neuron inducer SHH, which in
our conditions mimics in vitro its in vivo effects, as
described by Hynes (1995), does not seem to behave
as a trophic factor for DA neurons in vitro, as
described by Miao (1997). This difference could be
due to different culture conditions and to the
developmental stages ofDA cells.
The expression of genes encoding for neuronal
intermediate filaments shows that NFL and NFM
but not NFH are present in the expanded cultures.
The results indicate that still developing neurons
populate our expanded cultures, in agreement with
previous data from our and other laboratories,
showing that NFH appears in various CNS regions
late in development (Pemas-Alonso, 1996; Julien,
1986).
Interestingly, the addition of bFGF and SHH
to expand MES DA cultures does not induce glial
proliferation, as assessed by GFAP gene
expression, although it does not inhibit the
survival of glioblasts, which remains quiescent in
our culture conditions. On the whole, the
combined action of bFGF and SHH increases the
number of DA neurons but does not seem to
influence neuronal maturation, which takes place
after the withdrawal of bFGF and SHH, as shown
by the presence ofDA markers (Nurrl, TH, DAT,
cRet, VMAT2).
Differently, a maturation effect parallels the
increased number of DA neurons observed in our
cultures following AA administration, as shown by
increased TH and DAT mRNA, not observed in
cultures treated only with bFGF and SHH. Indeed,
whether AA acts through an inductive or a
selective mechanism remains to be established. A
similar effect of AA on bFGF-stimulated DA
neuroblasts was observed by Mckay and
collaborators (Yan, 2001) during cell passages,
suggesting that most of the effect observed by
these authors could be due to an increased survival
ofDA neurons.
The expanded primary cultures described here
provide several advantages. The expansion of
neuroblasts in the proliferative phase and the
enrichment in DA neurons can reduce the amount of
original embryonic DA neurons that is needed for
experimental or therapeutic grafting. The possibility
of protracting the culture period provides an
opportunity to generate cultures enriched in DA
neurons at various differentiation steps. The
controlled in vitro generation of DA neurons thus
offers an ideal tool to identify and to investigate the
function of still undetected genes implicated in the
differentiation ofDA neurons. Finally, our approach
offers the possibility of generating expanded
cultures from the ventral MES of single embryos at
early embryonic stages, thus allowing the study of
DA development and its dysfunction from
spontaneously mutated or genetically modified
animal models, even when they do not reach birth.
In this perspective, expanded DA primary cultures
from single embryos offer a useful system for
studying the molecular events involved in certain
DA neuropathologies like ADHD. As ADHD is a
pathology that mostly strikes males, expanded
primary cultures from single embryos could be
very useful for studying possible sex difference in
developing DA neurons and for testing the molecular
effects ofdrugs used in ADHD treatment.56 FLORIANA VOLPICELLI ET AL.
In conclusion, we have shown that it is
possible to enrich MES DA neurons in vitro by the
combined action of specific mitogens, morphogens,
and other inducer agents. This system is highly
appropriate to study molecular and cellular
mechanisms of the differentiation, function, and
survival ofDA neurons.
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